-
1دورية أكاديمية
المؤلفون: Sotiris Loizides, Anastasia Constantinidou
المصدر: Frontiers in Genetics, Vol 13 (2023)
مصطلحات موضوعية: immunotherapy, triple negative breast cancer, TIL (tumor infiltrating lymphocytes), tumor microenvironment, PD-L1 expression, Genetics, QH426-470
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fgene.2022.1095839/fullTest; https://doaj.org/toc/1664-8021Test
-
2دورية أكاديمية
المؤلفون: Ying Zhong, Xinyu Ren, Xi Cao, Yali Xu, Yu Song, Yidong Zhou, Feng Mao, Songjie Shen, Zhe Wang, Qiang Sun
المصدر: Frontiers in Oncology, Vol 12 (2022)
مصطلحات موضوعية: poor prognosis, triple negative breast cancer, TIL (tumor infiltrating lymphocytes), CD8+ TILs, IGF2R, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2022.871786/fullTest; https://doaj.org/toc/2234-943XTest
-
3مؤتمر
المؤلفون: Ying Zhong, Xinyu Ren, Xi Cao, Yali Xu, Yu Song, Yidong Zhou, Feng Mao, Songjie Shen, Zhe Wang, Qiang Sun
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, poor prognosis, triple negative breast cancer, TIL (tumor infiltrating lymphocytes), CD8+ TILs, IGF2R
الإتاحة: https://doi.org/10.3389/fonc.2022.871786.s001Test
https://figshare.com/articles/presentation/Presentation_1_Insulin-like_growth_factor_2_receptor_is_a_key_immune-related_gene_that_is_correlated_with_a_poor_prognosis_in_patients_with_triple-negative_breast_cancer_A_bioinformatics_analysis_pdf/21352059Test -
4دورية أكاديمية
المؤلفون: Thomas Duhen, Michael J. Gough, Rom S. Leidner, Sasha E. Stanton
المصدر: Frontiers in Oral Health, Vol 3 (2022)
مصطلحات موضوعية: OSCC (oral squamous cell carcinoma), HNSCC (head and neck squamous cell carcinoma), CD8, CD4, pre-malignancies, TIL (tumor infiltrating lymphocytes), Dentistry, RK1-715
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/froh.2022.902160/fullTest; https://doaj.org/toc/2673-4842Test
-
5دورية أكاديمية
المؤلفون: Sean J. Judge, Joshua D. Bloomstein, Cyrus J. Sholevar, Morgan A. Darrow, Kevin M. Stoffel, Logan V. Vick, Cordelia Dunai, Sylvia M. Cruz, Aryana M. Razmara, Arta M. Monjazeb, Robert B. Rebhun, William J. Murphy, Robert J. Canter
المصدر: Frontiers in Immunology, Vol 13 (2022)
مصطلحات موضوعية: soft tissue sarcoma (STS), NK cells, TIL (tumor infiltrating lymphocytes), immune infiltrate, T cells, immuno oncology, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fimmu.2022.893177/fullTest; https://doaj.org/toc/1664-3224Test
-
6دورية أكاديمية
المؤلفون: Eleonora Vecchio, Carmen Caiazza, Selena Mimmi, Angelica Avagliano, Enrico Iaccino, Teresa Brusco, Nancy Nisticò, Domenico Maisano, Annamaria Aloisio, Ileana Quinto, Maurizio Renna, Giuseppina Divisato, Simona Romano, Martina Tufano, Massimo D’Agostino, Elena Vigliar, Antonino Iaccarino, Chiara Mignogna, Francesco Andreozzi, Gaia Chiara Mannino, Rosangela Spiga, Mariano Stornaiuolo, Alessandro Arcucci, Massimo Mallardo, Giuseppe Fiume
المصدر: Frontiers in Cell and Developmental Biology, Vol 9 (2021)
مصطلحات موضوعية: metabolite profiling, TIL (tumor infiltrating lymphocytes), anti-tumor immunity, B16 engraftment, UDP, Biology (General), QH301-705.5
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fcell.2021.730726/fullTest; https://doaj.org/toc/2296-634XTest
-
7دورية أكاديمية
المؤلفون: Sarah A. Penny, Jennifer G. Abelin, Stacy A. Malaker, Paisley T. Myers, Abu Z. Saeed, Lora G. Steadman, Dina L. Bai, Stephen T. Ward, Jeffrey Shabanowitz, Donald F. Hunt, Mark Cobbold
المصدر: Frontiers in Immunology, Vol 12 (2021)
مصطلحات موضوعية: Immunopeptidomics, HLA-I phosphopeptides, tumor antigens, TIL (tumor infiltrating lymphocytes), CRC (colorectal cancer), signaling pathway, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fimmu.2021.723566/fullTest; https://doaj.org/toc/1664-3224Test
-
8دورية أكاديمية
المؤلفون: Sanjay Chandrasekaran, Christopher Ronald Funk, Troy Kleber, Chrystal M. Paulos, Mala Shanmugam, Edmund K. Waller
المصدر: Frontiers in Immunology, Vol 12 (2021)
مصطلحات موضوعية: adoptive cell immunotherapy, TIL (tumor infiltrating lymphocytes), CAR T cancer therapy, immune checkpoint inhibition (ICI), PI3K delta, PI3K gamma, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fimmu.2021.718621/fullTest; https://doaj.org/toc/1664-3224Test
-
9دورية أكاديمية
المؤلفون: Vecchio E., Caiazza C., Mimmi S., Avagliano A., Iaccino E., Brusco T., Nistico N., Maisano D., Aloisio A., Quinto I., Renna M., Divisato G., Romano S., Tufano M., D'agostino M., Vigliar E., Iaccarino A., Mignogna C., Andreozzi F., Mannino G. C., Spiga R., Stornaiuolo M., Arcucci A., Mallardo M., Fiume G.
المساهمون: Vecchio, E., Caiazza, C., Mimmi, S., Avagliano, A., Iaccino, E., Brusco, T., Nistico, N., Maisano, D., Aloisio, A., Quinto, I., Renna, M., Divisato, G., Romano, S., Tufano, M., D'Agostino, M., Vigliar, E., Iaccarino, A., Mignogna, C., Andreozzi, F., Mannino, G. C., Spiga, R., Stornaiuolo, M., Arcucci, A., Mallardo, M., Fiume, G.
مصطلحات موضوعية: Anti-tumor immunity, B16 engraftment, Metabolite profiling, TIL (tumor infiltrating lymphocytes), UDP
العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000717320100001; volume:9; firstpage:1; lastpage:13; numberofpages:13; journal:FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY; http://hdl.handle.net/11588/872378Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85116194842
-
10
المؤلفون: Xiaohui Pan, Bo Yang, Hongjie Guo, Shuyuan Cheng, Xi Chen, Ling Ding, Qiaojun He, Wenxin Zhang
المصدر: Acta Pharmaceutica Sinica B, Vol 10, Iss 5, Pp 723-733 (2020)
Acta Pharmaceutica Sinica. Bمصطلحات موضوعية: TIM-3, T cell immunoglobulin and mucin domain 3, H3K27me3, tri-methylation of lysine 27 on histone H3, MDSCs, myeloid-derived suppressor cells, medicine.medical_treatment, Review, TAA, tumor-associated antigen, DC, dendritic cell, 0302 clinical medicine, EZH2, enhancer of zeste homolog 2, LAG-3, lymphocyte activation gene-3, CTLA-4, cytotoxic T lymphocyte antigen 4, Medicine, BETi, bromodomain and extra-terminal motif inhibitors, General Pharmacology, Toxicology and Pharmaceutics, FOXP3, forkhead box P3, HDACi, histone deacetylase inhibitor, Cancer, 0303 health sciences, ACE1, angiotensin converting enzyme, CLL, chronic lymphocytic leukemia, biology, IDO, indoleamine 2,3-dioxygenase, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Tregs, regulatory T cells, PD-L1/PD-1 blockade, CCL22 (MDC), macrophage-derived chemokine, Immunotherapy, TET2, ten-eleven translocation 2, CTLs, cytotoxic T lymphocytes, FDA, U. S. Food and Drug Administration, PD-L1, programmed cell death ligand 1, T cell, CTA, cancer testis antigen, Immune cycle, TIL, tumor infiltrating lymphocytes, Epigenetic regulation, OS, overall survival, 03 medical and health sciences, Immune system, Antigen, PD-L1, TH-1, T helper type 1, DNMT1, DNA methyltransferase 1, MHC, major histocompatibility complex, CX3CL1, C-X3-C motif chemokine ligand 1, IFN-γ, interferon-gamma, 030304 developmental biology, business.industry, lcsh:RM1-950, biochemical phenomena, metabolism, and nutrition, medicine.disease, CXCL, CXC chemokine ligand, Blockade, lcsh:Therapeutics. Pharmacology, APC, antigen-presenting cell, UHRF1, ubiquitin-like PHD and RING finger domain-containing 1, 5-AzaC, 5-azacitidine, ACP1, human red cell acid phosphatase, biology.protein, Cancer research, bacteria, DNMTi, DNA methyltransferase inhibitors, PD-1, programmed cell death 1, business, PRC2, polycomb repressive complex 2
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1ca7b0479f6fea7a89a3e1eb06905c5Test
https://doi.org/10.1016/j.apsb.2019.09.006Test